Drugs.com - Pharma Industry News

Molecular Residual Disease Analysis May Predict Disease Recurrence After Lung Cancer Resection

TUESDAY, March 25, 2025 -- For patients with resected stage IB-IIIA epidermal growth factor receptor-mutated non-small cell lung cancer, molecular residual disease (MRD) precedes disease-free survival (DFS) events in patients receiving osimertinib...

Mar 25, 2025 - 19:04
 0
Molecular Residual Disease Analysis May Predict Disease Recurrence After Lung Cancer Resection
TUESDAY, March 25, 2025 -- For patients with resected stage IB-IIIA epidermal growth factor receptor-mutated non-small cell lung cancer, molecular residual disease (MRD) precedes disease-free survival (DFS) events in patients receiving osimertinib...
Read More

Tags:

Previous Article

Aquablation Appears to Be Safe, Effective for Enlarged Prostates

Next Article

Guidelines Developed for Management of Gastric Premalignant Conditions

Related Posts

Higher Calcium Intake Linked to Reduced Colorectal Cancer Risk

Higher Calcium Intake Linked to Reduced Colorectal Canc...

Feb 21, 2025  0

High Levels of Perimenopause-Related Symptoms Seen in Younger Women

High Levels of Perimenopause-Related Symptoms Seen in Y...

Mar 5, 2025  0

Western Dietary Pattern During Pregnancy Tied to Child Neurodevelopmental Disorders

Western Dietary Pattern During Pregnancy Tied to Child ...

Mar 12, 2025  0